RELAPSED OR REFRACTORY PLASMA CELL NEOPLASMS
Clinical trials for RELAPSED OR REFRACTORY PLASMA CELL NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new RELAPSED OR REFRACTORY PLASMA CELL NEOPLASMS trials appear
Sign up with your email to follow new studies for RELAPSED OR REFRACTORY PLASMA CELL NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Two-Pronged attack on tough blood cancers
Disease control Not yet recruitingThis early-stage study is testing a new type of CAR-T cell therapy designed to fight high-risk plasma cell cancers, like an aggressive form of multiple myeloma. The therapy is engineered to target two specific markers (BCMA and CD70) on cancer cells. The main goals are to check t…
Matched conditions: RELAPSED OR REFRACTORY PLASMA CELL NEOPLASMS
Phase: EARLY_PHASE1 • Sponsor: Affiliated Hospital to Academy of Military Medical Sciences • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New Two-Target cell therapy tested for Tough-to-Treat blood cancers
Disease control Not yet recruitingThis early-phase study is testing a new type of CAR-T cell therapy designed to target two markers (CD19 and BCMA) on cancer cells. It aims to see if this treatment is safe and effective for adults with advanced plasma cell cancers, like multiple myeloma, that have come back or st…
Matched conditions: RELAPSED OR REFRACTORY PLASMA CELL NEOPLASMS
Phase: EARLY_PHASE1 • Sponsor: Affiliated Hospital to Academy of Military Medical Sciences • Aim: Disease control
Last updated Mar 02, 2026 15:22 UTC